Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial.
Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E, Jeka S, Krueger K, Szechinski J, Alten R. Buttgereit F, et al. Among authors: szechinski j. Lancet. 2008 Jan 19;371(9608):205-14. doi: 10.1016/S0140-6736(08)60132-4. Lancet. 2008. PMID: 18207016 Clinical Trial.
Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial.
Kremer JM, Russell AS, Emery P, Abud-Mendoza C, Szechinski J, Westhovens R, Li T, Zhou X, Becker JC, Aranda R, Peterfy C, Genant HK. Kremer JM, et al. Among authors: szechinski j. Ann Rheum Dis. 2011 Oct;70(10):1826-30. doi: 10.1136/ard.2010.139345. Ann Rheum Dis. 2011. PMID: 21893583 Free PMC article. Clinical Trial.
A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis.
Lohmander LS, McKeith D, Svensson O, Malmenäs M, Bolin L, Kalla A, Genti G, Szechinski J, Ramos-Remus C; STAR Multinational Study Group. Lohmander LS, et al. Among authors: szechinski j. Ann Rheum Dis. 2005 Mar;64(3):449-56. doi: 10.1136/ard.2004.023572. Epub 2004 Sep 2. Ann Rheum Dis. 2005. PMID: 15345500 Free PMC article. Clinical Trial.
Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study.
Baranauskaite A, Raffayová H, Kungurov NV, Kubanova A, Venalis A, Helmle L, Srinivasan S, Nasonov E, Vastesaeger N; RESPOND investigators. Baranauskaite A, et al. Ann Rheum Dis. 2012 Apr;71(4):541-8. doi: 10.1136/ard.2011.152223. Epub 2011 Oct 12. Ann Rheum Dis. 2012. PMID: 21994233 Free PMC article. Clinical Trial.
Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis.
van der Heijde D, Da Silva JC, Dougados M, Geher P, van der Horst-Bruinsma I, Juanola X, Olivieri I, Raeman F, Settas L, Sieper J, Szechinski J, Walker D, Boussuge MP, Wajdula JS, Paolozzi L, Fatenejad S; Etanercept Study 314 Investigators. van der Heijde D, et al. Among authors: szechinski j. Ann Rheum Dis. 2006 Dec;65(12):1572-7. doi: 10.1136/ard.2006.056747. Epub 2006 Sep 12. Ann Rheum Dis. 2006. PMID: 16968715 Free PMC article. Clinical Trial.
Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
Mease PJ, Revicki DA, Szechinski J, Greenwald M, Kivitz A, Barile-Fabris L, Kalsi J, Eames J, Leirisalo-Repo M. Mease PJ, et al. Among authors: szechinski j. J Rheumatol. 2008 Jan;35(1):20-30. Epub 2007 Nov 15. J Rheumatol. 2008. PMID: 18050385 Clinical Trial.
Methotrexate in rheumatoid arthritis.
Swierkot J, Szechiński J. Swierkot J, et al. Among authors: szechinski j. Pharmacol Rep. 2006 Jul-Aug;58(4):473-92. Pharmacol Rep. 2006. PMID: 16963793 Free article. Review.
86 results